cell therapy, stem cells

Read the books about cell therapy logistics

  *Blog post provided by Thermo Fisher Scientific * Introduction to our Cell Therapy e-books If you have a cell-based therapy in development, then you need to consider such variables as packaging, storage, inventory management, monitoring systems, distribution, and even clinical site capabilities well before you begin to prepare the Investigational New Drug (IND) submission to the Food and Drug Administration (FDA). By sidestepping these issues …

The Stem Cells Regenerative Medicine Congress is where experts like Thermo Fisher Scientific go to network, learn from each other, and discuss the latest stem cell developments.

Thermo Fisher Scientific’s Amy Sinor on Optimizing Expansion of Stem Cells Without Compromising Pluripotency

Amy Sinor, Senior Research Scientist at Thermo Fisher Scientific, presented at the Stem Cells & Regenerative Medicine Congress in 2013. You can now download her presentation slides from the event, where she addresses optimized expansion of human induced pluripotent and embryonic stem cells without compromising pluripotency. You can now view the recording of her presentation alongside these slides, so that …

Thermo Fisher Scientific opens its Dry Powder Manufacturing facility to the attendees of the BioPharma Asia Convention 2014

           August 2nd 2013 marked the opening of Thermo Fisher Scientific’s Dry Powder Media (DPM) manufacturing facility in Singapore.  Dry powder media is a critical raw material used to manufacture biologics, including vaccines and anti-cancer therapeutics. The DPM facility is a 2,861 square meter facility, which mirrors the functionality and quality systems used in the United States.  The new manufacturing …